Abstract
Retinoid includes all natural or synthetic compounds based in vitamin A (Vit. A) similar activity, thereby has the ability to activate nuclear retinoid receptors. Through the discovery of nuclear receptors for retinoic acid, greater understanding of mechanism of action of these compounds was achieved. Such advance allows also the possibility of development of molecules with specific roles in various pathological affections that are the cause of many diseases.
These receptors are coupled to certain regions of DNA that are responsive to activation by retinol and/or retinoic acid. Subsequently, the message is transcribed (messenger RNA) to ribosomes, where proteins are synthesized. Therefore, they end up acting at the cellular differentiation, embryonic morphogenesis, and carcinogenesis.
Retinoids are classified into generations. The first generation: retinoic acid (RA), tretinoin or acid vitamin A, alitretinoin (9 cis-retinoic acid), and isotretinoin (13 cis-retinoic acid). They are all isomers and naturally occur in the organism.
Acitretin and its precursor etretinate are the second-generation retinoids.
The more recent third generation is represented by adapalene, tazarotene, motretinide, and arotinoides.
Retinoids have a large number of indications. According to the indication, their use can be topical or systemic. Their benefits range from anti-inflammatory action, immunomodulatory effects, and more recently of photoaging.
A huge list of possible adverse effects must be known in order to minimize the risk. They are essentially dose dependent.
References
Armstrong RB, Kim HJ. Retinoids for the future: investigational approaches for the identification of new compounds. J Am Acad Dermatol. 1992;27(6 Pt 2):S38–42.
Azulay DR, Azulay-Abulafia L, Costa JA, Sodré CT. Tecido de granulação exuberante. Efeito colateral da terapêutica com isotretinoína. An Bras Dermatol. 1985;60:179–82.
Bavinck JN, Tieben LM, Van der Woude FJ, et al. Prevention of skin lesion and reduction of keratotic skin lesion during acitretin therapy in renal transplant recipients. J Clin Oncol. 1995;13(8):1933–8.
Berbis P, Bun H, Geiger JM. Acitretin and oral contraceptives: interaction study. Arch Dermatol Res. 1988;280(6):388–9.
Bressan AL, Gripp AC, Oliveira EF, Silva RS. Síndrome de extravasamento capilar sistêmico. An Bras Dermatol. 2011;86(3):593–5.
DiGiovanna JJ. Retinoids for the future: oncology. J Am Acad Dermatol. 1992;27(6 Pt 2):S34–7.
DiGiovanna JJ. Isotretinoin effects on bone. J Am Acad Dermatol. 2001;45(5):S176–82.
Dong D, Ruuska SE, Levinthal DJ, et al. Distinct roles for retinoic acid-binding proteins I and II in regulating signaling by retinoic acid. J Biol Chem. 1999;274(34):23695–8.
Ellis CN, Krach KJ. Uses and complications of isotretinoin therapy. J Am Acad Dermatol. 2001;45(5):S150–7.
Elmazar MM, et al. Pattern of retinoid-induced teratogenic effects related to receptor RAR alpha, RAR beta and RAR gamma. Teratology. 1996;53(3):158–67.
Frankel SR, Eardley A, Lauwers G, Weiss M, Warrell Jr RP. The “retinoic acid syndrome” in acute leukemia. Ann Intern Med. 1992;117(4):292–6.
Jacobs DG, Deutsch NL, Brewer M. Suicide, depression and isotretinoin: is there a causal link? J Am Acad Dermatol. 2001;45(5):S168–75.
Jick H. Retinoids and teratogenicity. J Am Acad Dermatol. 1998;39(2 Pt 3):S118–22.
Kang S, Li XY, Duell EA, et al. The retinoid X receptor agonist 9-cis-retinoic acid and the 24-hydroxylase inhibitor ketoconazole increase activity of 1,25-dihydroxyvitamin D3 in human skin in vivo. J Invest Dermatol. 1997;108(4):513–8.
Katz HI, Waalen J, Leach EE. Acitretin in psoriasis: an overview of adverse effects. J Am Acad Dermatol. 1999;41(3 Pt 2):S7–12.
Lee AG. Pseudotumor cerebri after treatment with tetracycline and isotretinoin for acne. Cutis. 1995;55(3):165–8.
Liu PT, Krutzik SR, Kim J, Modlin RL. Cutting edge: all-trans retinoic acid down-regulates TLR2 expression and function. J Immunol. 2005;174(5):2467–70.
Marqueling AL, Zane LT. Depression and suicidal behavior in acne patients treated with isotretinoin: a systematic review. Semin Cutan Med Surg. 2005;24(2):92–102.
Marqueling AL, Zane LT. Depression and suicidal behavior in acne patients treated with isotretinoin: a systematic review. Semin Cutan Med Surg. 2007;26(4):210–20.
Miles S. The importance of screening for laser-assisted in situ keratomileusis operation (LASIK) before prescribing isotretinoin. J Am Acad Dermatol. 2006;54(1):180–1.
Nguyen EQH, Wolverton SE. Systemic retinoids. In: Wolverton SE, editor. Comprehensive dermatologic drug therapy. 1st ed. Philadelphia: WB Saunders; 2001.
Petkovich PM. Retinoic acid metabolism. J Am Acad Dermatol. 2001;45(5):S136–42.
Rabello-Fonseca RM, Chieppe J, Avè M, Cuzzi T, Azulay DR, Manela-Azulay M. Isotretinoína oral: uso em dermatologia. Rev Soc Port Dermatol Venereol. 2006;64(3):309–24.
Rabello-Fonseca RM, Azulay DR, Luiz RR, Mandarim-de-Lacerda CA, Cuzzi T, Manela-Azulay M. Oral isotretinoin in photoaging: clinical and histopathological evidence of efficacy of an off-label indication. J Eur Acad Dermatol Venereol. 2009;23(2):115–23.
Raso PB, Avelleira JCR, Azulay DR. Granulation tissue in palpebral conjunctivae associated with acitretin. J Am Acad Dermatol. 2008;58(2 Suppl):S41–2.
Riganti J, Caviedes MP, Torre AC, Maqueda MG, et al. Lingual ulceration associated with retinoic acid syndrome during treatment of acute promyelocytic leukemia. Int J Dermatol. 2014;53(7):912–6.
Ruzicka T, Lynde CW, Jemec GB, et al. Efficacy and safety of oral alitretinoin in patients with severe chronic hand eczema refractory to topical steroids. Br J Dermatol. 2008;158(4):808–17.
Sardana R, Seghal N. Retinoids fascinating up-and-coming scenario. J Dermatol. 2003;30(5):355–80.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this entry
Cite this entry
Azulay, D.R., Vendramini, D.L. (2016). Retinoids. In: Issa, M., Tamura, B. (eds) Daily Routine in Cosmetic Dermatology. Clinical Approaches and Procedures in Cosmetic Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-319-20250-1_15-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-20250-1_15-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Online ISBN: 978-3-319-20250-1
eBook Packages: Springer Reference MedicineReference Module Medicine